Altre lingue Ekso Bionics Holdings, Inc.

Azioni

EKSO

US2826443010

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 01/05/2024			Variaz. 5gg	Var. 1 gen.
1,275 ^USD	+2,82%		+8,05%	-49,00%

29/04	Transcript : Ekso Bionics Holdings, Inc., Q1 2024 Earnings Call, Apr 29, 2024
29/04	Ekso Bionics Holdings, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Ekso Bionics: Q1 Earnings Snapshot	29/04
Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q1 Revenue $3.8M, vs. Street Est of $5M	29/04
Ekso Bionics Announces First Quarter 2024 Financial Results	29/04
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024	22/04
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal	12/04
Certain Warrants of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	17/03
Certain Common Stock of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	17/03
Ekso Bionics: Q4 Earnings Snapshot	04/03
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/03
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04/03
Ekso Bionics Reports Record Annual Revenue of $18.3 Million	04/03
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024	26/02
Ekso Bionics Announces $4.6 Million Registered Direct Offering	11/01
Ekso Bionics Launches GaitCoach Software for EksoNR	08/01
Ekso Bionics Holdings, Inc. Launches GaitCoach Software for EksoNR	08/01
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results	04/01
Ekso Bionics Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023	04/01
Ekso Bionics : Investor Presentation	18/12
Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal	12/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ekso Bionics Holdings, Inc.

Azioni

EKSO

US2826443010

Altre lingue

Filtri